TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54 | +14.9% | 155,500 | +54.7% | 0.00% | – |
| Q2 2023 | $47 | -17.5% | 100,500 | +21.7% | 0.00% | – |
| Q1 2023 | $57 | -25.0% | 82,598 | +14.5% | 0.00% | – |
| Q4 2022 | $76 | -100.0% | 72,155 | -17.1% | 0.00% | -100.0% |
| Q3 2021 | $672,000 | -61.7% | 87,000 | -52.4% | 0.00% | -50.0% |
| Q2 2021 | $1,756,000 | +100.0% | 182,700 | +182.4% | 0.00% | +100.0% |
| Q1 2021 | $878,000 | +75.2% | 64,700 | +84.9% | 0.00% | 0.0% |
| Q4 2020 | $501,000 | -74.8% | 34,994 | -67.5% | 0.00% | -50.0% |
| Q3 2020 | $1,987,000 | +155.1% | 107,600 | -20.4% | 0.00% | +100.0% |
| Q2 2020 | $779,000 | – | 135,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |